News

FDA approves alirocumab, first injectable lipid-lowering biologic therapy

Publish date: July 24, 2015

 

FROM THE FDA

References

The prescribing information is available at http://1.usa.gov/1KpIU82.

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

WCD: Psoriasis plus depression magnifies MI risk
MDedge Cardiology
ADA: DPP4 inhibitors and cardiovascular outcomes: connecting the dots
MDedge Cardiology
EULAR: Panel previews updated CVD recommendations
MDedge Cardiology
FDA approves cangrelor, an intravenous antiplatelet drug
MDedge Cardiology
Half of Hispanics unaware of their high cholesterol
MDedge Cardiology
Rosacea linked to dyslipidemia, hypertension, CAD
MDedge Cardiology
Study quantifies risks linked to cardiac multimorbidity
MDedge Cardiology
FDA will strengthen heart attack, stroke risk warnings for all NSAIDs
MDedge Cardiology
Cardiovascular disease prevention should start in childhood
MDedge Cardiology
ACC/AHA cholesterol guideline found efficient, cost effective
MDedge Cardiology

Related Articles